Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
26.07.2016 23:09:57

Edwards Lifesciences Corp. Announces 31% Increase In Q2 Earnings

(RTTNews) - Edwards Lifesciences Corp. (EW) reported a profit for its second quarter that advanced compared to the same period last year.

The company said its bottom line totaled $164.6 million, or $0.76 per share. This was up from $125.7 million, or $0.57 per share, in last year's second quarter.

Analysts had expected the company to earn $0.70 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 23.1% to $759.3 million. This was up from $616.8 million last year.

Edwards Lifesciences Corp. earnings at a glance:

-Earnings (Q2): $164.6 Mln. vs. $125.7 Mln. last year. -Earnings Growth (Y-o-Y): 30.9% -EPS (Q2): $0.76 vs. $0.57 last year. -EPS Growth (Y-o-Y): 33.3% -Analysts Estimate: $0.70 -Revenue (Q2): $759.3 Mln vs. $616.8 Mln last year. -Revenue Change (Y-o-Y): 23.1%

-Guidance: Next quarter EPS guidance: $0.62 - $0.68 Next quarter revenue guidance: $720 - $760 Mln Full year EPS guidance: $2.78 - $2.88 Full year revenue guidance: $2.7 - $3.0 Bln

Analysen zu Edwards Lifesciences Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Edwards Lifesciences Corp. 67,68 -0,72% Edwards Lifesciences Corp.